DFNA5 Polyclonal Antibody

Hearing impairment is a heterogeneous condition with over 40 loci described. Non-syndromic hearing impairment protein 5 encoded by DFNA5 is expressed in fetal cochlea, however, its function is not known. Nonsyndromic hearing impairment is associated with a mutation in this gene. Three transcript variants encoding two different isoforms have been found for this gene.

The DFNA5 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of DFNA5 protein expression. This antibody is produced using advanced immunization techniques, ensuring high affinity and sensitivity. With its polyclonal nature, it recognizes multiple epitopes of the DFNA5 protein, enhancing the accuracy and versatility of experimental results.

The DFNA5 Polyclonal Antibody exhibits exceptional performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It enables researchers to investigate the expression patterns and subcellular localization of DFNA5 in different tissues and cell types. Its robustness and reproducibility make it an ideal choice for both basic research and clinical studies.

This antibody is manufactured under stringent quality control measures, guaranteeing batch-to-batch consistency and reliability. It is validated for use in multiple species, including human, mouse, and rat, ensuring broad applicability across various experimental models. The DFNA5 Polyclonal Antibody is supplied in a convenient liquid format, allowing for easy handling and storage.

In summary, the DFNA5 Polyclonal Antibody is a valuable tool for researchers seeking to explore the role and function of DFNA5 protein. Its high specificity, sensitivity, and versatility make it an indispensable asset in the field of molecular biology and biomedical research.